Merck, NewLink Ebola vaccine appears safe, effective in new studies

April 1, 2015 9:00 PM

11 0

NEW YORK (Reuters) - Early-stage trials of an experimental Ebola vaccine, two in the United States and four in Africa and Europe, have found that it appears to be safe and triggered robust production of Ebola-fighting antibodies, scientists reported on Wednesday.

Since trials cannot ethically expose volunteers to Ebola, the production of antibodies is a proxy for whether vaccines could prevent or even treat the disease.

Read more

To category page